Oci Nv:企業の戦略・SWOT・財務分析

◆英語タイトル:Oci Nv - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3437
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Oci Nv – Strategy, SWOT and Corporate Finance Report
Summary

Oci Nv – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

OCI NV (OCI) is a producer and distributor of natural gas-based fertilizers and industrial chemicals. Its product portfolio includes anhydrous ammonia, granular urea, urea ammonium nitrate (UAN), calcium ammonium nitrate (CAN), methanol, melamine, diesel exhaust fluid and other natural gas based products. The company also distributes crystalline and granular ammonium sulphate (AS). It serves agriculture and industrial customers globally through its own production and third party traded products. The company operates through several production facilities which include OCI Nitrogen plant, and M1 and M2 methanol plants in the Netherlands, Sorfert Algerie in Algeria, Egyptian Fertilizers Company (EFC) and EBIC in Egypt, and OCI Beaumont in the US. OCI is headquartered in Amsterdam, the Netherlands.

Scope

- Detailed information on Oci Nv required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Oci Nv in the form of a SWOT analysis
- An in-depth view of the business model of Oci Nv including a breakdown and examination of key business segments
- Intelligence on Oci Nv’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Oci Nv, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Oci Nv and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Oci Nv as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Oci Nv’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
OCI NV: Company Overview
OCI NV: Overview and Key Facts
OCI NV: Overview
OCI NV: Key Facts
OCI NV: Key Employees
OCI NV: Key Employee Biographies
OCI NV: Major Products and Services
OCI NV: Company History
OCI NV: Management Statement
OCI NV: Locations and Subsidiaries
OCI NV: Key Competitors
OCI NV: Company Analysis
OCI NV: Business Description
OCI NV: SWOT Analysis
OCI NV: SWOT Overview
OCI NV: Strengths
OCI NV: Weaknesses
OCI NV: Opportunities
OCI NV: Threats
OCI NV: Corporate Financial Deals Activity
OCI NV: Financial Deals Overview
OCI NV: Targets and Partners
OCI NV: Top Deals 2015 – 2019YTD*
OCI NV: Advisors
OCI NV: Top Legal Advisors
OCI NV: Top Financial Advisors
OCI NV: Mergers and Acquisitions
OCI NV: Capital Raising
OCI NV: Partnership
OCI NV: Divestments
OCI NV: Recent Developments
OCI NV: News and Events Summary
OCI NV: Business Expansion
OCI NV: Corporate Governance
OCI NV: Financial Performance
OCI NV: Regulatory and Legal Events
OCI NV: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: OCI NV: Key Facts
Table 2: OCI NV: Key Employees
Table 3: OCI NV: Company History
Table 4: OCI NV: Locations and Subsidiaries
Table 5: OCI NV: Key Competitors
Table 6: OCI NV: Deal Activity by Deal Type - Volume (TTM*)
Table 7: OCI NV: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: OCI NV: M&A Average Deal Size - Value (US$m)
Table 9: OCI NV: Targets and Partners
Table 10: OCI NV: Top Deals 2015 - 2019YTD*
Table 11: OCI NV: Legal Advisor Ranking by Value (US$m)
Table 12: OCI NV: Financial Advisor Ranking by Value (US$m)
Table 13: OCI NV: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: OCI NV: M&A Activity by Geography (2015 - YTD*2019)
Table 15: OCI NV: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 16: OCI NV: Capital Raising by Deal Type (2015 - YTD*2019)
Table 17: OCI NV: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 18: OCI NV: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 19: OCI NV: Divestments by Geography (2015 - YTD*2019)
Table 20: OCI NV: News and Events Summary
Table 21: OCI NV: Business Expansion
Table 22: OCI NV: Corporate Governance
Table 23: OCI NV: Financial Performance
Table 24: OCI NV: Regulatory and Legal Events
Table 25: OCI NV: Strategy and Operations

★海外企業調査レポート[Oci Nv:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • equensWorldline SE:企業の戦略・SWOT・財務情報
    equensWorldline SE - Strategy, SWOT and Corporate Finance Report Summary equensWorldline SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kyokuyo Co., Ltd.
    Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ipsen SA (IPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases. The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products …
  • Qatar Electricity & Water Co QPSC:企業の発電所・SWOT分析2018
    Qatar Electricity & Water Co QPSC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Sitara Chemical Industries Ltd (SITC):企業の財務・戦略的SWOT分析
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Medshape Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc, is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company provides products such as dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft …
  • Genus Power Infrastructures Ltd (GENUSPOWER):企業の財務・戦略的SWOT分析
    Summary Genus Power Infrastructures Ltd (Genus Power), a subsidiary of Kailash Group, is an electronic equipment manufacturer that develops and distributes electric energy equipment. The company’s products include metering solution products, engineering construction and contracts, solar energy solut …
  • Total Energy Services Inc. (TOT):企業の財務・戦略的SWOT分析
    Total Energy Services Inc. (TOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ok Tedi Mining Ltd:企業の戦略・SWOT・財務情報
    Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務分析
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As:企業の戦略・SWOT・財務分析
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • AG Insurance SA/NV:企業の戦略・SWOT・財務情報
    AG Insurance SA/NV - Strategy, SWOT and Corporate Finance Report Summary AG Insurance SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • VistaGen Therapeutics Inc (VTGN):医療機器:M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • Synaffix BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • San Miguel Corp:企業の戦略・SWOT・財務情報
    San Miguel Corp - Strategy, SWOT and Corporate Finance Report Summary San Miguel Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Myovant Sciences Ltd (MYOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Myovant Sciences Ltd (Myovant), a subsidiary of Roivant Sciences Ltd, is a biopharmaceutical company that develops and commercializes new treatments for women’s diseases and endocrine disorders. The company’s products include relugolix, an oral small molecule that functions as a gonadotropin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆